LivaNova's third quarter of 2025 showcased robust organic revenue growth, significant gains in the cardiopulmonary and epilepsy segments, and improved financial metrics. However, challenges remain with component supply constraints affecting expansion and negative impacts from currency and tariff changes. Despite these challenges, the company has raised its full-year guidance, reflecting a positive outlook.

Company Guidance

In the third quarter of 2025, LivaNova plc reported a strong financial performance with a 13% organic revenue growth compared to the previous year, driven by robust cardiopulmonary and epilepsy business segments. The Cardiopulmonary segment saw a 16% revenue increase, reaching $203 million, while epilepsy revenue rose by 6%. The company has raised its full-year 2025 cardiopulmonary revenue growth guidance to 12.5%-13.5% and overall organic revenue growth outlook by 50 basis points to 9.5%-10.5%. Adjusted gross margin was slightly decreased to 69%, impacted by currency changes and product mix, while adjusted operating income grew to $80 million, translating to a 23% margin. The adjusted diluted earnings per share was $1.11, and the company reported a strong cash position with $646 million as of September 30. Additionally, the full-year guidance for 2025 now includes revenue growth of 8.5%-9.5% on a constant currency basis, with adjusted diluted earnings per share projected at $3.80-$3.90.

Strong Organic Revenue Growth

LivaNova delivered 13% organic revenue growth in the third quarter of 2025, driven by the cardiopulmonary business and solid epilepsy performance across all regions.

Cardiopulmonary Segment Performance

Revenue for the Cardiopulmonary segment increased by 16% versus the third quarter of 2024, with Heart-lung machine revenue growing over 20%.

Epilepsy Segment Growth

Epilepsy revenue increased by 6% versus the third quarter of 2024. Growth in Europe and Rest of World regions increased by 12%, while U.S. epilepsy revenue increased by 5% year-over-year.

Improved Financial Metrics

Adjusted operating income increased to $80 million from $64 million in the third quarter of 2024, and adjusted diluted earnings per share rose to $1.11 from $0.90.

Updated 2025 Guidance

Full-year 2025 revenue growth is now forecasted to be between 8.5% and 9.5% on a constant currency basis and between 9.5% and 10.5% on an organic basis.

LivaNova (LIVN) Earnings, Revenues Date & History

The upcoming earnings date is based on a company’s previous reporting, and may be updated when the actual date is announced

Daily Earnings Calendar >

LIVN Earnings History

Report Date	Fiscal Quarter	Forecast / EPS	Last Year's EPS	EPS YoY Change	Slides	Play Transcript
Feb 25, 2026	2025 (Q4)	0.81 / -	0.81	―	―	―
Nov 05, 2025	2025 (Q3)	0.92 / 1.11	0.9	23.33% (+0.21)
Aug 06, 2025	2025 (Q2)	0.87 / 1.05	0.93	12.90% (+0.12)
May 07, 2025	2025 (Q1)	0.76 / 0.88	0.73	20.55% (+0.15)
Feb 25, 2025	2024 (Q4)	0.80 / 0.81	0.87	-6.90% (-0.06)
Oct 30, 2024	2024 (Q3)	0.72 / 0.90	0.73	23.29% (+0.17)
Jul 31, 2024	2024 (Q2)	0.78 / 0.93	0.78	19.23% (+0.15)
May 01, 2024	2024 (Q1)	0.49 / 0.73	0.43	69.77% (+0.30)
Feb 21, 2024	2023 (Q4)	0.77 / 0.87	0.81	7.41% (+0.06)
Nov 01, 2023	2023 (Q3)	0.64 / 0.73	0.58	25.86% (+0.15)

The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.

Beat

Missed

LIVN Earnings-Related Price Changes

Report Date	Price 1 Day Before	Price 1 Day After	Percentage Change
Nov 05, 2025	$53.94	$50.81	-5.80%
Aug 06, 2025	$42.61	$47.36	+11.15%
May 07, 2025	$35.16	$43.50	+23.72%
Feb 25, 2025	$49.50	$41.70	-15.76%

Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.

FAQ

When does LivaNova PLC (LIVN) report earnings?

LivaNova PLC (LIVN) is schdueled to report earning on Feb 25, 2026, Before Open (Confirmed).

What is LivaNova PLC (LIVN) earnings time?

LivaNova PLC (LIVN) earnings time is at Feb 25, 2026, Before Open (Confirmed).

Where can I see when companies are reporting earnings?

You can see which companies are reporting today on our designated earnings calendar.

What companies are reporting earnings today?

You can see a list of the companies which are reporting today on TipRanks earnings calendar.

What is LIVN EPS forecast?

LIVN EPS forecast for the fiscal quarter 2025 (Q4) is 0.81.

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing